COVID-19

(084) A Cohort Study to Evaluate the Real-World Utilization and Effectiveness of Bebtelovimab Compared to Nirmatrelvir/Ritonavir among Patients with Mild-to-Moderate COVID-19 Who Are at High Risk for Progressing to Severe Illness

(085) Alterations in Influenza Management - the Potential Influence of the COVID-19 Pandemic

(086) Assessing the Robustness of Comparative Effectiveness Studies: An Applied Example Evaluating the Effectiveness of Bebtelovimab In COVID-19

(087) Association of Substance Use Disorder and Risk of COVID-19-related Outcomes Among Adults in Hong Kong

(088) Capturing Information Not Presented in Hazard Ratios: The Added Value of Presenting Plots of Instantaneous Hazards for Time-To-Event Analyses

(089) Characterisation of ICNARC COVID-19 data

(091) Characterization of select laboratory test in administrative healthcare data and data from commercial laboratories among patients with COVID-19 diagnosed in outpatient settings

(092) Characterizing Post-COVID Muscle Weakness Using Structured and Unstructured Electronic Health Records

(093) Cohort event monitoring of COVID-19 vaccine safety using patient-reported outcomes in lactating women.

(094) Concomitant prescribing of nirmatrelvir/ritonavir (NMV-r) and medications with potential risk for drug-drug interaction – a feasibility assessment of Truveta Electronic Health Records Database.

(095) COVID-19 Lockdown and the Osteoporosis Treatment Among US Medicare Enrollees Who Initiated Romosozumab

(096) COVID-19 Pandemic and the Consumption of Self-Care Products for Pediculosis Capitis in Portugal: An Interrupted Time-Series Analysis

(097) COVID-19 Related Changes in Healthcare Utilization Among Insured Persons in the US and its Impact on Pharmacoepidemiologic Research

(098) Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults: A Retrospective Inception Cohort Study

(099) Distinguishing Hospital Encounters as "with" vs "for" COVID-19 Using A Large US Administrative Claims Database

(100) Drug Shortages in the U.S. and Canada Prior to and During the COVID-19 Pandemic: A Multi-National, Cross-Sectional Study

(101) Effectiveness of pre-pregnancy maternal SARS-CoV-2 vaccination in preventing COVID-19 in infants

(102) Evaluation of postmenopausal hemorrhage following Moderna COVID-19 vaccines: results from surveillance data analysis and interim results from a US claims database cohort study

(103) Evaluation of Two Methods in Minimizing Confounding by Indication Bias in Observational Research: an Example Based on Guideline-recommended COVID-19 therapies

(104) Healthcare Utilization Among People Living With Long COVID 2.5 Years After Acute COVID-19

(106) Impact of allergic conditions on COVID-19 susceptibility and outcomes

(107) Impact of the COVID-19 pandemic and control measures on screening and diagnoses of type 2 diabetes in British Columbia

(108) Impact of Treatment of COVID-19 with Sotrovimab on Post-Acute COVID-19 Syndrome: An Analysis of National COVID Cohort Collaborative (N3C) Data

(109) Incidence Rate of Long COVID Among Overweight or Obese Adults Who Had COVID-19 Infection in the United Kingdom

(110) Influenza and SARS-CoV-2 coinfection: A Rapid Review of Epidemiological Literature 2020-2023

(111) Inhaled corticosteroid use associated with severity of COVID-19 diagnosis among patients with asthma, a cohort study

(112) Investigating Previous Antibiotic Exposure Patterns among COVID-19 Hospitalised Patients: An OpenSAFELY Matched Case-Control Study

(113) Investigation of the Consumption Trend of Inhalants Used in the Treatment of Obstructive Airway Diseases During the COVID-19 Pandemic

(114) New Medication Use in Post-Acute Sequelae Of COVID-19 (PASC): An EHR-based Study From the RECOVER Program

(115) Nirmatrelvir and Ritonavir (Paxlovid) Prognostication: Unveiling Utilization Trends with Neural Network Time Series Forecasting

(116) Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe Covid-19: An Analysis of the National Covid Cohort Collaborative (N3C)

(117) Outcomes in patients hospitalized with severe COVID-19 treated with add-on immunomodulatory agents

(119) Performance of the US Food and Drug Administration’s COVID-19 Disease Severity Categorization for Use in Real-World Data

(120) Post-COVID Conditions: Prevalence and Associated Factors in Individuals with Intellectual Disabilities in Sweden

(121) Potential for Differential Outcome Misclassification in United States Claims Data during the COVID-19 Era: An Applied Example

(122) Prenatal-, Birth- and Post-Partum- Related Experiences among Women who were Pregnant in First Three Waves of the COVID-19 Pandemic in Canada: a Study Within the CONCEPTION Cohort.

(123) Racial and language disparities in initial COVID-19 vaccination during lactation

(124) Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation

(125) Reproducibility of computable phenotypes for post-acute sequelae of COVID-19 (PASC) in US administrative claims data

(126) Risk Factors for Long-Term Cardiovascular Post-Acute Sequelae of COVID-19 Infection: a Nested Case-Control Study

(127) Risk factors for severe outcomes among patients hospitalized with COVID-19 in US Medicare between December 2020 and March 2023

(128) Safety of Moderna mRNA-1273.214 and mRNA-1273.222 COVID-19 bivalent vaccines: results from post-marketing surveillance in South Korea

(129) Safety of Moderna’s mRNA-1273.222 bivalent omicron-containing vaccine: interim results from a US claims database cohort study

(131) Survival of critically ill COVID-19 patients in Sweden during the first two-and-a-half years of the pandemic

(132) The Association Between Asthma and Outcomes of COVID-19

(133) The Comparative Effectiveness of Baricitinib And Tocilizumab in Hospitalized Patients With Covid: A Retrospective Cohort Study of The National Covid Cohort Collaborative (N3C)

(134) The Impact of COVID-19 Containment Strictness on the Administration of Romosozumab among Medicare Enrollees in the Most Socioeconomically Vulnerable Counties in the US

(136) The Impact of COVID-19 Pandemic on the Consumption of Anti-hypertensive, Anti-diabetes and Anti-hyperlipidemic Medications.

(137) The impact of prenatal maternal depression during the COVID-19 pandemic on maternal postpartum depression: A prospective cohort study within the CONCEPTION study.

(138) The risks of immune- and inflammatory related post-acute sequelae of COVID-19: a network study in 6 European countries, the US, and Korea

(139) Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic

(140) Use of Ursodeoxycholic Acid and the Risk of Long COVID in Patients with Steatotic Liver Disease